封面
市場調查報告書
商品編碼
1379138

2023-2028 年血液製備市場報告(按產品、抗血栓和抗凝血劑類型、抗血栓和抗凝血劑應用和地區)

Blood Preparation Market Report by Product, Antithrombotic and Anticoagulants Type, Antithrombotic and Anticoagulants Application, and Region 2023-2028

出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3個工作天內

價格

概要

2022年全球血液製劑市場規模達到423億美元。展望未來, IMARC Group預計到2028年市場規模將達到5,61億美元,2022-2028年複合年成長率(CAGR)為4.9%。

捐血是一種挽救生命的程序,其中從捐血者身上抽取一個單位的血液。這种血液由細胞元素、膠體和晶體的混合物組成,需要將其分離才能用於患者。因此,血液製備方法被廣泛採用,利用冷凍離心設備將一個單位的全血分離成不同的成分。這些成分通常包括冷沉澱、濃縮血小板、新鮮冷凍血漿和濃縮紅血球 (PRBC) 濃縮物。此血液製備方法也最大化了每种血液成分對於不同應用的效用。

血液製備市場趨勢:

由於冠狀病毒病(COVID-19)病例激增且缺乏有效的治療方法,多家醫院正在依靠恢復期血漿作為危重患者的一種有希望的治療方法。這是積極影響從健康捐血中分離血漿的血液製備方法需求的關鍵因素之一。除此之外,貧血、鐮狀細胞病、血友病和癌症等慢性疾病的日益流行正在刺激對輸血的需求。由於世界各地政府和非政府組織(NGO)的宣傳活動,捐血者數量不斷增加,這共同促進了市場的成長。與此一致的是,外科手術數量的大幅增加也促進了市場的成長。此外,一些醫療機構正致力於採用先進的數位技術來快速分離血液成分。他們還利用射頻識別(RFID)技術來維護血液庫存記錄,預計這將在未來幾年擴大血液製備方法的應用。

本報告回答的關鍵問題

  • 2022年全球血液製劑市場規模有多大?
  • 2023-2028年全球血液製劑市場的預期成長率是多少?
  • 推動全球血液製劑市場的關鍵因素是什麼?
  • COVID-19 對全球血液製劑市場有何影響?
  • 基於該產品的全球血液製劑市場的詳細情形如何?
  • 根據抗血栓和抗凝血劑類型,全球血液製劑市場的細分如何?
  • 基於抗血栓和抗凝血劑應用的全球血液製劑市場的詳細情形如何?
  • 全球血液製劑市場的重點區域有哪些?
  • 全球血液製劑市場的主要參與者/公司有哪些?

目錄

第 1 章:前言

第 2 章:範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章:執行摘要

第 4 章:簡介

  • 概述
  • 主要行業趨勢

第 5 章:全球血液製備市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章:按產品分類的市場區隔

  • 全血
    • 市場走向
    • 關鍵環節
      • 紅血球
      • 粒細胞
      • 電漿
      • 血小板
    • 市場預測
  • 血液成分
    • 市場走向
    • 關鍵環節
      • 全血成分
      • 濃縮紅血球
      • 白血球減少 紅血球
      • 冷凍血漿
      • 濃縮血小板
      • 冷沉澱
    • 市場預測
  • 血液衍生物
    • 市場走向
    • 市場預測

第 7 章:按抗血栓和抗凝血劑類型分類的市場細分

  • 血小板聚集抑制劑
    • 市場走向
    • 關鍵環節
      • 糖蛋白抑制劑
      • COX抑制劑
      • ADP拮抗劑
      • 其他
    • 市場預測
  • 纖溶藥物
    • 市場走向
    • 關鍵環節
      • 組織纖溶酶原活化劑 (TPA)
      • 鏈激酶
      • 尿激酶
    • 市場預測
  • 抗凝血劑
    • 市場走向
    • 關鍵環節
      • 肝素
      • 維生素 K 拮抗劑
      • 直接凝血酶抑制劑
      • 直接 Xa 因子抑制劑
    • 市場預測

第 8 章:抗血栓和抗凝血劑應用的市場區隔

  • 血小板增多症
    • 市場走向
    • 市場預測
  • 肺栓塞
    • 市場走向
    • 市場預測
  • 腎功能不全
    • 市場走向
    • 市場預測
  • 心絞痛血管併發症
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章:按地區分類的市場區隔

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 10 章:SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章:價值鏈分析

第 12 章:波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章:價格分析

第14章:競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Baxter International Inc.
    • Boehringer Ingelheim International GmbH
    • Bristol-Myers Squibb Company
    • Daiichi Sankyo Company Limited
    • GlaxoSmithKline PLC
    • Johnson & Johnson Services Inc.
    • LEO Pharma A/S
    • Pfizer Inc.
    • Portola Pharmaceuticals Inc. (Alexion Pharmaceuticals Inc.)
    • Sanofi SA
Product Code: SR112023A4552

Abstract

The global blood preparation market size reached US$ 42.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 56.1 Billion by 2028, exhibiting a growth rate (CAGR) of 4.9% during 2022-2028.

Blood donation is a lifesaving procedure wherein one unit of blood is taken from the donor. This blood consists of a mixture of cellular elements, colloids, and crystalloids, which need to be separated for being used in patients. As a result, the blood preparation method is widely adopted to separate one-unit whole blood into different components using refrigerated centrifuge equipment. These components generally include cryoprecipitate, platelet concentrate, fresh frozen plasma, and packed red blood cell (PRBC) concentrate. The blood preparation method also maximizes the utility of each blood component for a different applications.

Blood Preparation Market Trends:

Due to the surging cases of coronavirus disease (COVID-19) and the lack of effective treatment, several hospitals are relying on convalescent plasma as a promising treatment for patients with critical conditions. This represents one of the key factors positively influencing the need for blood preparation methods to separate plasma from healthy blood donations. Apart from this, the growing prevalence of chronic disorders, such as anemia, sickle cell disease, hemophilia, and cancer, is catalyzing the demand for blood transfusion. This, in confluence with the rising number of blood donors on account of awareness campaigns conducted by governmental and non-governmental organizations (NGOs) worldwide, is contributing to the market growth. In line with this, a significant rise in the number of surgical procedures is also bolstering the growth of the market. Moreover, several healthcare institutions are focusing on employing advanced digital technologies for the speedy separation of blood components. They are also utilizing radio frequency identification (RFID) technology for maintaining blood inventory records, which is anticipated to expand the application of blood preparation methods in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global blood preparation market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, antithrombotic and anticoagulants type, and antithrombotic and anticoagulants application.

Breakup by Product:

Whole Blood

Red Cells

Granulocytes

Plasma

Platelets

Blood Components

Whole Blood Components

Packed Red Cells

Leukocyte Reduced Red Blood Cells

Frozen Plasma

Platelet Concentrate

Cryoprecipitate

Blood Derivatives

Breakup by Antithrombotic and Anticoagulants Type:

Platelet Aggregation Inhibitors

Glycoprotein Inhibitors

COX Inhibitors

ADP Antagonists

Others

Fibrinolytics

Tissue Plasminogen Activator (TPA)

Streptokinase

Urokinase

Anticoagulants

Heparins

Vitamin K Antagonists

Direct Thrombin Inhibitors

Direct Factor Xa Inhibitors

Breakup by Antithrombotic and Anticoagulants Application:

Thrombocytosis

Pulmonary Embolism

Renal Impairment

Angina Blood Vessel Complications

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Baxter International Inc., Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Daiichi Sankyo Company Limited, GlaxoSmithKline PLC, Johnson & Johnson Services Inc., LEO Pharma A/S, Pfizer Inc., Portola Pharmaceuticals Inc. (Alexion Pharmaceuticals Inc.) and Sanofi S.A.

Key Questions Answered in This Report

  • 1. What was the size of the global blood preparation market in 2022?
  • 2. What is the expected growth rate of the global blood preparation market during 2023-2028?
  • 3. What are the key factors driving the global blood preparation market?
  • 4. What has been the impact of COVID-19 on the global blood preparation market?
  • 5. What is the breakup of the global blood preparation market based on the product?
  • 6. What is the breakup of the global blood preparation market based on the antithrombotic and anticoagulants type?
  • 7. What is the breakup of the global blood preparation market based on the antithrombotic and anticoagulants application?
  • 8. What are the key regions in the global blood preparation market?
  • 9. Who are the key players/companies in the global blood preparation market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Blood Preparation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Whole Blood
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Red Cells
      • 6.1.2.2 Granulocytes
      • 6.1.2.3 Plasma
      • 6.1.2.4 Platelets
    • 6.1.3 Market Forecast
  • 6.2 Blood Components
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Whole Blood Components
      • 6.2.2.2 Packed Red Cells
      • 6.2.2.3 Leukocyte Reduced Red Blood Cells
      • 6.2.2.4 Frozen Plasma
      • 6.2.2.5 Platelet Concentrate
      • 6.2.2.6 Cryoprecipitate
    • 6.2.3 Market Forecast
  • 6.3 Blood Derivatives
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Antithrombotic and Anticoagulants Type

  • 7.1 Platelet Aggregation Inhibitors
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Glycoprotein Inhibitors
      • 7.1.2.2 COX Inhibitors
      • 7.1.2.3 ADP Antagonists
      • 7.1.2.4 Others
    • 7.1.3 Market Forecast
  • 7.2 Fibrinolytics
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Tissue Plasminogen Activator (TPA)
      • 7.2.2.2 Streptokinase
      • 7.2.2.3 Urokinase
    • 7.2.3 Market Forecast
  • 7.3 Anticoagulants
    • 7.3.1 Market Trends
    • 7.3.2 Key Segments
      • 7.3.2.1 Heparins
      • 7.3.2.2 Vitamin K Antagonists
      • 7.3.2.3 Direct Thrombin Inhibitors
      • 7.3.2.4 Direct Factor Xa Inhibitors
    • 7.3.3 Market Forecast

8 Market Breakup by Antithrombotic and Anticoagulants Application

  • 8.1 Thrombocytosis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pulmonary Embolism
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Renal Impairment
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Angina Blood Vessel Complications
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Baxter International Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Boehringer Ingelheim International GmbH
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Bristol-Myers Squibb Company
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Daiichi Sankyo Company Limited
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 GlaxoSmithKline PLC
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Johnson & Johnson Services Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 LEO Pharma A/S
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 Pfizer Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Portola Pharmaceuticals Inc. (Alexion Pharmaceuticals Inc.)
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Sanofi S.A.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Blood Preparation Market: Major Drivers and Challenges
  • Figure 2: Global: Blood Preparation Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Blood Preparation Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Blood Preparation Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Blood Preparation Market: Breakup by Antithrombotic and Anticoagulants Type (in %), 2022
  • Figure 6: Global: Blood Preparation Market: Breakup by Antithrombotic and Anticoagulants Application (in %), 2022
  • Figure 7: Global: Blood Preparation Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Blood Preparation (Whole Blood) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Blood Preparation (Whole Blood) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Blood Preparation (Blood Components) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Blood Preparation (Blood Components) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Blood Preparation (Blood Derivatives) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Blood Preparation (Blood Derivatives) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Blood Preparation (Platelet Aggregation Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Blood Preparation (Platelet Aggregation Inhibitors) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Blood Preparation (Fibrinolytics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Blood Preparation (Fibrinolytics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Blood Preparation (Anticoagulants) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Blood Preparation (Anticoagulants) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Blood Preparation (Thrombocytosis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Blood Preparation (Thrombocytosis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Blood Preparation (Pulmonary Embolism) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Blood Preparation (Pulmonary Embolism) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Blood Preparation (Renal Impairment) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Blood Preparation (Renal Impairment) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Blood Preparation (Angina Blood Vessel Complications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Blood Preparation (Angina Blood Vessel Complications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Blood Preparation (Other Antithrombotic and Anticoagulant Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Blood Preparation (Other Antithrombotic and Anticoagulant Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: North America: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: North America: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: United States: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: United States: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Canada: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Canada: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Asia-Pacific: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Asia-Pacific: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: China: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: China: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Japan: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Japan: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: India: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: India: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: South Korea: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: South Korea: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Australia: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Australia: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Indonesia: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Indonesia: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Others: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Others: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Europe: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Europe: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Germany: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Germany: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: France: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: France: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: United Kingdom: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: United Kingdom: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Italy: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Italy: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Spain: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Spain: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Russia: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Russia: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Others: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Others: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Latin America: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Latin America: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Brazil: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Brazil: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Mexico: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Mexico: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Others: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Others: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Middle East and Africa: Blood Preparation Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Middle East and Africa: Blood Preparation Market: Breakup by Country (in %), 2022
  • Figure 78: Middle East and Africa: Blood Preparation Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Global: Blood Preparation Industry: SWOT Analysis
  • Figure 80: Global: Blood Preparation Industry: Value Chain Analysis
  • Figure 81: Global: Blood Preparation Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Blood Preparation Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Blood Preparation Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Blood Preparation Market Forecast: Breakup by Antithrombotic and Anticoagulants Type (in Million US$), 2023-2028
  • Table 4: Global: Blood Preparation Market Forecast: Breakup by Antithrombotic and Anticoagulants Application (in Million US$), 2023-2028
  • Table 5: Global: Blood Preparation Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Blood Preparation Market: Competitive Structure
  • Table 7: Global: Blood Preparation Market: Key Players